Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.John C. Byrd, C. D. Bloomfield, Maria R. Baer et al.|Journal of Clinical Oncology|1997Cited by 236
Morphologic characteristics of erythroleukemia (Acute Myeloid Leukemia; FAB‐M6): A CALGB studyFR Davey, Clara D. Bloomfield, Neethu Abraham et al.|American Journal of Hematology|1995Cited by 54